Opioid maker Insys files for Chapter 11 bankruptcy
Group buckles under weight of legal liabilities in wake of US addiction crisis (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - June 10, 2019 Category: Pharmaceuticals Source Type: news

Researchers look to " magic mushrooms " to treat depression
New trials have shown the drug psilocybin - the active ingredient of magic mushrooms - to be effective in treating depression, and U.S. cities are starting to decriminalize it. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - June 10, 2019 Category: Pharmaceuticals Source Type: news

St. Elizabeth opens women ’s health center
St. Elizabeth Healthcare has opened a Women ’s Health Center in Edgewood in renovated space previously occupied by the Northern Kentucky Health Department. The 15,100-square-foot center at 600-610 Medical Village Drive, which is on the campus of St. Elizabeth’s flagship hospital, provides screening mammography, bone density scans (also k nown as a DEXA scan), pelvic floor physical therapy and urogynecology services.  The center is open to patients, and St. Elizabeth will host a grand opening… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 10, 2019 Category: Pharmaceuticals Authors: Barrett J. Brunsman Source Type: news

2019 Business of Pride: Maggie Henjum, Motion
In 2016, Henjum founded Motion, a physical therapy clinic in St. Paul that expanded to a second location in Minnetonka last year. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 10, 2019 Category: Pharmaceuticals Authors: Elizabeth Millard Source Type: news

Merck snaps up preclinical Lexington biotech for up to $773M
Tilos Therapeutics, a quiet preclinical biotech developing treatments for cancer and autoimmune diseases, has become the latest startup to be acquired by pharmaceutical giant Merck& Co. Merck (NYSE: MRK) announced Monday that it has agreed to pay upwards of $773 million in upfront and milestone payments for the purchase. A company spokesperson declined to disclose how much Merck paid upfront. Privately held Tilos was founded in 2016 by Boehringer Ingelheim Venture Fund and Partn ers Healthcare’s… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 10, 2019 Category: Pharmaceuticals Authors: Allison DeAngelis Source Type: news

AI study in London offers hope for MS treatment
Researchers use computer algorithms to track changes in hundreds of MRI brain scans (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - June 10, 2019 Category: Pharmaceuticals Source Type: news

Opioid Maker Insys Files For Chapter 11 Bankruptcy
Opioid manufacturer Insys Therapeutics filed for Chapter 11 bankruptcy protection on Monday. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 10, 2019 Category: Pharmaceuticals Authors: Michela Tindera, Forbes Staff Source Type: news

Merck to buy Tilos Therapeutics in deal valued at up to $773 million
Merck& Co. Inc, in its second megadeal involving a cancer therapy developer in as many months, entered into a definitive agreement Monday to acquire Tilos Therapeutics in a transaction valued up to $773 million. Tilos, based in Lexington, Mass., is a biopharmaceutical company that has developed a portfolio of new drug candidates that employ a novel approach to modulating the potent signaling molecule known as TGFβ. TGFβ is believed to play an important role in the development of cancer and fibrotic… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 10, 2019 Category: Pharmaceuticals Authors: John George Source Type: news

$4.8 billion deal for gene therapy pioneer Spark Therapeutics delayed once more
The finish line for their proposed $4.8 billion deal is proving to be quite elusive for Roche and Spark Therapeutics. The companies announced Monday they have have each received a request for additional information and documentary material from the Federal Trade Commission in connection with the FTC's review of Roche’s pending acquisition of Spark (NASDAQ: ONCE), a Philadelphia gene therapy company. The reques t extends the waiting period for action on the proposed deal — part of the regulatory… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 10, 2019 Category: Pharmaceuticals Authors: John George Source Type: news

This innovation could be a lifesaver for women
Men are more likely than women to receive CPR in public. The creators of a new fabric attachment that gives manikins more womanly features hope to change that. New York ad agency JOAN Creative and organization The United State of Women developed the Womanikin, which attaches to a manikin used during CPR practice and gives the manikin breasts, reports CNN.  “The vast majority of us learn on a flat-chested torso. This universal attachment will change that. The Womanikin won’t solve everything,… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 10, 2019 Category: Pharmaceuticals Authors: Caitlin Mullen Source Type: news

HCA Healthcare looks to raise nearly $5B
HCA Healthcare Inc. (NYSE: HCA) filed paperwork with the Securities and Exchange Commission June 6 that could help the Nashville, Tennessee-based company raise some serious cash. The hospital giant — which has a major Houston presence — will offer $4.9 billion of senior secured notes with the intent to use proceeds for “general corporate purposes and the redemption of certain outstanding indebtedness,” according to the filing. These notes are in addition to a $1 b illion offering announced… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 10, 2019 Category: Pharmaceuticals Authors: Joel Stinnett Source Type: news

Big Slick raises its biggest total yet for Children ’s Mercy
The Big Slick Celebrity Weekend raised a record $2.5 million for Children ’s Mercy Cancer Center. The star-studded fundraiser went big in its 10th year, moving its closing show and auction to Sprint Center. It paid off, with the event besting last year’s record of $2.2 million raised. Big Slick began as a poker tournament featuring hometown actors Rob Riggle, Paul Rudd and Jason Sudeikis. It soon picked up David Koechner and Eric Stonestreet and has expanded each year. This year’s activities… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 10, 2019 Category: Pharmaceuticals Authors: Brian Kaberline Source Type: news

Eiger Appoints Industry Veteran and Regulatory Affairs Expert Mark Mannebach, PhD, RPh as Vice President of Global Regulatory Affairs
PALO ALTO, Calif., June 10, 2019 -- (Healthcare Sales & Marketing Network) -- Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), focused on the development and commercialization of therapies for rare and ultra-rare diseases, today announced the appointment of... Biopharmaceuticals, Personnel Eiger BioPharmaceuticals, lonafarnib (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 10, 2019 Category: Pharmaceuticals Source Type: news

Surprise Billing: Another Healthcare Market Failure
Patients often assume that their health insurance will cover emergency care or major procedures. They're caught by surprise when they find out that they ’re not fully covered. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 10, 2019 Category: Pharmaceuticals Authors: Joshua Cohen, Contributor Source Type: news

The $2.1 Million Question: What Are The Medical, Ethical Implications Of The World's Priciest Drug?
Excessive drug prices, unnecessary medical procedures and other forms of healthcare waste are ethically wrong and, if left unchecked, will prove deadly. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 10, 2019 Category: Pharmaceuticals Authors: Robert Pearl, M.D., Contributor Source Type: news

Oncologie Closes an $80M Series B Financing for Clinical-Stage Pipeline
BOSTON, June 10, 2019 -- (Healthcare Sales & Marketing Network) -- Oncologie, an innovative biopharmaceutical company using proprietary biomarkers to drive clinical development of next-generation oncology therapeutics, announced today that it has closed a... Biopharmaceuticals, Oncology, Venture Capital Oncologie, bavituximab (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 10, 2019 Category: Pharmaceuticals Source Type: news

Aridis Pharmaceuticals Appoints Dr. Susan Windham-Bannister to Board of Directors
SAN JOSE, Calif., June 10, 2019 -- (Healthcare Sales & Marketing Network) -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of targeted immunotherapies using fully human monoclonal antibod... Biopharmaceuticals, Personnel Aridis Pharmaceuticals, MabIgX (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 10, 2019 Category: Pharmaceuticals Source Type: news

Lumenis Proudly Showcases a Wide Range of Technologies for Multiple Skin and Body Applications at the 24and#7511;and#688; World Congress of Dermatology (WCD) 2019
MILAN, June 10, 2019 -- (Healthcare Sales & Marketing Network) -- Lumenis Ltd, the world's largest energy-based medical device company for aesthetic, surgical, and ophthalmic applications, is proud to be showcasing a wide range of novel technologies for s... Devices, Dermatology Lumenis, Legend Pro+, SPLENDOR X, BLEND X, PiQo4 (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 10, 2019 Category: Pharmaceuticals Source Type: news

Exclusive: Multibillion-dollar private equity firm plans Nashville office, moving senior leadership
The firm is a subsidiary of New York City-based C.V. Starr& Co. Inc., which is led by Chairman and CEO Maurice “Hank” Greenberg. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 10, 2019 Category: Pharmaceuticals Authors: Joel Stinnett Source Type: news

Hyperglycemia in Pregnancy May Up Risk for Obesity in Offspring
MONDAY, June 10, 2019 -- Pregnancy hyperglycemia at levels below the threshold for gestational diabetes mellitus (GDM) and maternal obesity are associated with childhood obesity, according to a study recently published in PLOS ONE. Samantha F.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 10, 2019 Category: Pharmaceuticals Source Type: news

Irregular Sleep Patterns May Increase Risk for Metabolic Syndrome
MONDAY, June 10, 2019 -- Variability in sleep duration and timing is associated with higher odds of metabolic syndrome, according to a study published online June 5 in Diabetes Care. Tianyi Huang, Sc.D., and Susan Redline, M.D., M.P.H., both from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 10, 2019 Category: Pharmaceuticals Source Type: news

Fewer New T2DM Cases Seen in Adults on Plant-Based Diet
MONDAY, June 10, 2019 -- Fewer new type 2 diabetes (T2D) cases are seen in adults who eat more plant-based foods, and intake of vitamins B2 and B6 is also associated with a reduced risk for T2D, according to two studies presented during Nutrition... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 10, 2019 Category: Pharmaceuticals Source Type: news

Rapid Fluid Removal May Up Mortality in Critically Ill With AKI
MONDAY, June 10, 2019 -- Among critically ill patients with acute kidney injury, use of higher net ultrafiltration (NUF) rates for continuous venovenous hemodiafiltration is associated with lower survival, according to a secondary analysis published... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 10, 2019 Category: Pharmaceuticals Source Type: news

Half an Hour of Sun Exposure Daily May Lower Risk for Pediatric IBD
MONDAY, June 10, 2019 -- Higher sun exposure in the previous summer or winter is associated with a lower risk for having pediatric inflammatory bowel disease (IBD), according to a study recently published in the Journal of Pediatric Gastroenterology... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 10, 2019 Category: Pharmaceuticals Source Type: news

Location of Body Fat Linked to Advanced, Fatal Prostate Cancer
MONDAY, June 10, 2019 -- Specific fat deposits, body mass index (BMI), and waist circumference are associated with an increased risk for advanced and fatal prostate cancer, according to a study published online June 10 in Cancer. Barbra A.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 10, 2019 Category: Pharmaceuticals Source Type: news

Access to Health Care Has Little Impact on Longevity
MONDAY, June 10, 2019 -- Health care has modest effects on extending life expectancy in the United States, while behavioral and social determinants may have larger effects, according to a review published in the May/June issue of the Annals of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 10, 2019 Category: Pharmaceuticals Source Type: news

Cough Sound Analyzer Helps Differentiate Peds Respiratory Disorders
MONDAY, June 10, 2019 -- An automated cough sound analyzer can serve as a diagnostic aid in the assessment of pediatric respiratory disorders, according to a study published online June 6 in Respiratory Research. Paul Porter, M.B.B.S., from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 10, 2019 Category: Pharmaceuticals Source Type: news

2003 to 2014 Saw Incidence of Herpes Zoster Drop in Children
MONDAY, June 10, 2019 -- From 2003 to 2014, there was a decrease in herpes zoster (HZ) incidence among children, with lower incidence rates for varicella-vaccinated versus unvaccinated children, according to a study published online June 10 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 10, 2019 Category: Pharmaceuticals Source Type: news

Mouth Rinse for HPV DNA May Be Biomarker in Head, Neck Cancer
MONDAY, June 10, 2019 -- Human papillomavirus (HPV) DNA detected from a mouth rinse may be an effective marker for prognosis during treatment of HPV-positive head and neck cancer, according to a study recently published in JAMA Oncology. Carole... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 10, 2019 Category: Pharmaceuticals Source Type: news

Breaking Down the Alexander-Murray Senate Health Reform Plan
The recent Alexander-Murray health reform package attempts to unleash the power of market competition to reduce costs and improve care. While not perfect, its inclusion of measures to improve price transparency, ban anti-competitive practices, and boost vaccination rates are on the right track. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 10, 2019 Category: Pharmaceuticals Authors: Sally Pipes, Contributor Source Type: news

Google Ran A Secret Experiment To Search For Cold Fusion. Did They Find It?
Google invested $10 million over the past 4 years in a series of experiments to see if cold fusion could really work. They just published their results. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 10, 2019 Category: Pharmaceuticals Authors: Steven Salzberg, Contributor Source Type: news

Will The Introduction Of A Third Potent Cholesterol Lowering Drug Expand or Shrink The Market?
Payers still will want to limit access to these drugs given the massive number of patients that could be eligible for treatment. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 10, 2019 Category: Pharmaceuticals Authors: John LaMattina, Contributor Source Type: news

FDA approves first chemoimmunotherapy regimen for patients with relapsed or refractory diffuse large B-cell lymphoma
Today, the U.S. Food and Drug Administration granted accelerated approval to Polivy (polatuzumab vedotin-piiq), in combination with the chemotherapy bendamustine and a rituximab product (a combination known as "BR"), to treat adult patients with diffuse large B-cell lymphoma (DLBCL) that has progressed or returned after at least two prior therapies. Polivy is a novel antibody-drug conjugate, and DLBCL is the most common type of non-Hodgkin lymphoma. (Source: World Pharma News)
Source: World Pharma News - June 10, 2019 Category: Pharmaceuticals Tags: Featured FDA Regulatory Affairs Source Type: news

Regulators hold up Roche’s $5bn Spark acquisition
Wait period extended after watchdogs in US and UK request more information about deal (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - June 10, 2019 Category: Pharmaceuticals Source Type: news

Study finds FDA dermatology advisors receive payments following drug approvals
A team of researchers led by a member of the University of Colorado School of Medicine faculty at the Anschutz Medical Campus examined post-advisory financial relationships between U.S. physicians who advised FDA committees during dermatological drug approval processes. Critics of these industry-physician relationships claim these types of payments could incentivize advisors to alter their voting habits. (Source: World Pharma News)
Source: World Pharma News - June 10, 2019 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Roche and Spark Therapeutics, Inc. receive Request for Additional Information from FTC under Hart-Scott-Rodino Act and announce extension of tender offer for shares of Spark Therapeutics, Inc.
Roche and Spark Therapeutics, Inc. ( “Spark”) today announced that they have each received a request for additional information and documentary material (the “Second Request”) from the U.S. Federal Trade Commission (the “FTC”) in connection with the FTC’s review of Roche’s pending acquisition of Spark. (Source: Roche Investor Update)
Source: Roche Investor Update - June 10, 2019 Category: Pharmaceuticals Source Type: news

Roche and Spark Therapeutics, Inc. receive Request for Additional Information from FTC under Hart-Scott-Rodino Act and announce extension of tender offer for shares of Spark Therapeutics, Inc.
Roche and Spark Therapeutics, Inc. ( “Spark”) today announced that they have each received a request for additional information and documentary material (the “Second Request”) from the U.S. Federal Trade Commission (the “FTC”) in connection with the FTC’s review of Roche’s pending acquisition of Spark. (Source: Roche Media News)
Source: Roche Media News - June 10, 2019 Category: Pharmaceuticals Source Type: news

Study: Our Gut Bacteria May Be Dismantling The Pills We Take - What You Should Know
New research reveals that our gut bacteria digest and metabolize many of the common drugs we take, and we're just now starting to understand the implications of this potentially big finding. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 10, 2019 Category: Pharmaceuticals Authors: David DiSalvo, Contributor Source Type: news

Solid Form Selection in Drug Development, New Webinar Hosted by Xtalks
Drug formulators should consider the physical properties of their products during pharmaceutical drug development. The physical properties of a solid drug substance are highly dependent on the solid...(PRWeb June 10, 2019)Read the full story at https://www.prweb.com/releases/solid_form_selection_in_drug_development_new_webinar_hosted_by_xtalks/prweb16366118.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 10, 2019 Category: Pharmaceuticals Source Type: news

Overcoming Temperature Challenges in the Clinical Supply Chain, New...
Cold chain supply management is becoming increasingly important given the rise in biologics and biosimilar type drugs. Companies need to be aware of how to select appropriate packaging, labelling and...(PRWeb June 10, 2019)Read the full story at https://www.prweb.com/releases/overcoming_temperature_challenges_in_the_clinical_supply_chain_new_webinar_hosted_by_xtalks/prweb16366045.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 10, 2019 Category: Pharmaceuticals Source Type: news

Initial Determination Finds ACON ’s 3-1 Lipid Panels Infringe PTS...
United States International Trade Commission issues initial determination finding ACON’s 3-1 Lipid Panels infringe PTS Diagnostics’ Patent Nos. 7,087,397 and 7,625,721(PRWeb June 10, 2019)Read the full story at https://www.prweb.com/releases/initial_determination_finds_acons_3_1_lipid_panels_infringe_pts_diagnostics_patents/prweb16363926.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 10, 2019 Category: Pharmaceuticals Source Type: news

Prestige Scientific Expands Executive Search Firm to Europe
Prestige Scientific Hires Director for First European Office(PRWeb June 10, 2019)Read the full story at https://www.prweb.com/releases/prestige_scientific_expands_executive_search_firm_to_europe/prweb16364087.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 10, 2019 Category: Pharmaceuticals Source Type: news

Compound Solutions Inc. pursues goBHB ® patent violators,...
Compound Solutions has a long history of working with its partners to strongly defend its intellectual property (IP). Customers trust CSI to defend its IP and provide unique ingredients they can...(PRWeb June 10, 2019)Read the full story at https://www.prweb.com/releases/compound_solutions_inc_pursues_gobhb_patent_violators_continues_to_defend_ip_and_win_customers/prweb16364353.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 10, 2019 Category: Pharmaceuticals Source Type: news

Improved Pharma Publishes Review Article in AAPS PharmSciTech
Improved Pharma LLC has published a review article on predictive and accelerated formulation design. The authors discuss ways of using synchrotron methods to improve the drug development process,...(PRWeb June 10, 2019)Read the full story at https://www.prweb.com/releases/improved_pharma_publishes_review_article_in_aaps_pharmscitech/prweb16352435.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 10, 2019 Category: Pharmaceuticals Source Type: news

Doctors warn of NHS workforce ‘crisis’ over pension tax rules
Consultants refusing to take on extra work for fear of busting new limitations (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - June 10, 2019 Category: Pharmaceuticals Source Type: news

New psoriasis drug study yields positive results: Dr Reddy's
According to a press release from the city-based drug-maker, the detailed safety and efficacy data from the study would be presented in future dermatology conferences. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 10, 2019 Category: Pharmaceuticals Source Type: news

Children Shouldn't Work On Fields, But On Their Dreams!
It is crucial to recognize the link between poverty and child labor and combat both to ensure that children do not work on fields, but on their dreams. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 9, 2019 Category: Pharmaceuticals Authors: Ewelina U. Ochab, Contributor Source Type: news

When A Suspected Brain Tumor Turns Out To Be A Parasite
Neurocysticercosis is when the pork tapeworm literally gets in your head. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 9, 2019 Category: Pharmaceuticals Authors: Bruce Y. Lee, Contributor Source Type: news

Blue State Seniors Like Private Medicare Advantage Despite Single Payer Push
Seniors in Democratic-leaning states are choosing private Medicare Advantage plans more so than the national average, Kaiser Family Foundation data shows. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 9, 2019 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Source Type: news

Blue State Seniors Like Private Medicare, Complicating Single Payer
Seniors in Democratic-leaning states are choosing private Medicare Advantage plans more so than the national average, Kaiser Family Foundation data shows. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 9, 2019 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Source Type: news